It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A spinal cord injury usually spares some components of the locomotor circuitry. Deep brain stimulation (DBS) of the midbrain locomotor region and epidural electrical stimulation of the lumbar spinal cord (EES) are being used to tap into this spared circuitry to enable locomotion in humans with spinal cord injury. While appealing, the potential synergy between DBS and EES remains unknown. Here, we report the synergistic facilitation of locomotion when DBS is combined with EES in a rat model of severe contusion spinal cord injury leading to leg paralysis. However, this synergy requires high amplitudes of DBS, which triggers forced locomotion associated with stress responses. To suppress these undesired responses, we link DBS to the intention to walk, decoded from cortical activity using a robust, rapidly calibrated unsupervised learning algorithm. This contingency amplifies the supraspinal descending command while empowering the rats into volitional walking. However, the resulting improvements may not outweigh the complex technological framework necessary to establish viable therapeutic conditions.
Deep brain stimulation and epidural electrical stimulation of the spinal cord enable locomotion in humans with spinal cord injury (SCI) but the potential synergy between both approaches is unclear. The authors show that a complex technological approach is required to enable volitional walking in rats with SCI.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Ecole Polytechnique Fédérale de Lausanne (EPFL), Bertarelli Foundation Chair in Translational Neuroengineering, Center for Neuroprosthetics and Institute of Bioengineering, School of Bioengineering, Lausanne, Switzerland (GRID:grid.5333.6) (ISNI:0000000121839049)
2 Swiss Federal Institute of Technology (EPFL), Center for Neuroprosthetics and Brain Mind Institute, School of Life Sciences, Geneva, Switzerland (GRID:grid.5333.6) (ISNI:0000000121839049); Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Department of Clinical Neuroscience, Lausanne, Switzerland (GRID:grid.8515.9) (ISNI:0000 0001 0423 4662); CHUV/UNIL/EPFL, Defitech Center for Interventional Neurotherapies (.NeuroRestore), Lausanne, Switzerland (GRID:grid.414250.6) (ISNI:0000 0001 2181 4933)
3 Swiss Federal Institute of Technology (EPFL), Center for Neuroprosthetics and Brain Mind Institute, School of Life Sciences, Geneva, Switzerland (GRID:grid.5333.6) (ISNI:0000000121839049); Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Department of Clinical Neuroscience, Lausanne, Switzerland (GRID:grid.8515.9) (ISNI:0000 0001 0423 4662); CHUV/UNIL/EPFL, Defitech Center for Interventional Neurotherapies (.NeuroRestore), Lausanne, Switzerland (GRID:grid.414250.6) (ISNI:0000 0001 2181 4933); Pavlov Institute of Physiology, Motor Physiology Laboratory, St. Petersburg, Russia (GRID:grid.417772.0) (ISNI:0000 0001 2217 1298)
4 Swiss Federal Institute of Technology (EPFL), Center for Neuroprosthetics and Brain Mind Institute, School of Life Sciences, Geneva, Switzerland (GRID:grid.5333.6) (ISNI:0000000121839049); Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Department of Clinical Neuroscience, Lausanne, Switzerland (GRID:grid.8515.9) (ISNI:0000 0001 0423 4662); Pavlov Institute of Physiology, Neuromorphology Laboratory, St. Petersburg, Russia (GRID:grid.417772.0) (ISNI:0000 0001 2217 1298)
5 Ecole Polytechnique Fédérale de Lausanne (EPFL), Bertarelli Foundation Chair in Translational Neuroengineering, Center for Neuroprosthetics and Institute of Bioengineering, School of Bioengineering, Lausanne, Switzerland (GRID:grid.5333.6) (ISNI:0000000121839049); Scuola Superiore Sant’Anna, The BioRobotics Institute, Pisa, Italy (GRID:grid.263145.7) (ISNI:0000 0004 1762 600X)
6 Swiss Federal Institute of Technology (EPFL), Center for Neuroprosthetics and Brain Mind Institute, School of Life Sciences, Geneva, Switzerland (GRID:grid.5333.6) (ISNI:0000000121839049); Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Department of Clinical Neuroscience, Lausanne, Switzerland (GRID:grid.8515.9) (ISNI:0000 0001 0423 4662); CHUV/UNIL/EPFL, Defitech Center for Interventional Neurotherapies (.NeuroRestore), Lausanne, Switzerland (GRID:grid.414250.6) (ISNI:0000 0001 2181 4933); CHUV, Department of Neurosurgery, Lausanne, Switzerland (GRID:grid.8515.9) (ISNI:0000 0001 0423 4662)